Search research articles
Contact Us
Filters
Showing results (151-160 of 249) with videos related to
Page
of 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2005
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy
Bryan T Hennessy, Gabriel N Hortobagyi, Roman Rouzier, et al.
BMC Cancer
|
February 21, 2023
An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer
Ahmed Rashed, Orla M Fitzpatrick, David J Easty, et al.
Diabetes
|
April 24, 2026
Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes
Giang M Dao, Sam Zhao, Cara Schofield, et al.
Oncotarget
|
November 22, 2017
A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib
John O'Shea, Mattia Cremona, Clare Morgan, et al.
The Oncologist
|
September 4, 2007
Trends for inflammatory breast cancer: is survival improving?
Ana M Gonzalez-Angulo, Bryan T Hennessy, Kristine Broglio, et al.
Molecular Cancer Therapeutics
|
August 24, 2012
Mechanistic basis for overcoming platinum resistance using copper chelating agents
Zheng D Liang, Yan Long, Wen-Bin Tsai, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
November 13, 2014
BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer
L Flanagan, A U Lindner, C de Chaumont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy
Mark S Carey, Roshan Agarwal, Blake Gilks, et al.
BMC Medicine
|
April 13, 2017
S100β as a serum marker in endocrine resistant breast cancer
Sara Charmsaz, Éamon Hughes, Fiona T Bane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Pharmacodynamic markers of perifosine efficacy
Bryan T Hennessy, Yiling Lu, Enrique Poradosu, et al.
Page
of 25
Search research articles
Search
Showing results (151-160 of 249) with videos related to
Sort By:
Page
of 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2005
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy
Bryan T Hennessy, Gabriel N Hortobagyi, Roman Rouzier, et al.
BMC Cancer
|
February 21, 2023
An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer
Ahmed Rashed, Orla M Fitzpatrick, David J Easty, et al.
Diabetes
|
April 24, 2026
Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes
Giang M Dao, Sam Zhao, Cara Schofield, et al.
Oncotarget
|
November 22, 2017
A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib
John O'Shea, Mattia Cremona, Clare Morgan, et al.
The Oncologist
|
September 4, 2007
Trends for inflammatory breast cancer: is survival improving?
Ana M Gonzalez-Angulo, Bryan T Hennessy, Kristine Broglio, et al.
Molecular Cancer Therapeutics
|
August 24, 2012
Mechanistic basis for overcoming platinum resistance using copper chelating agents
Zheng D Liang, Yan Long, Wen-Bin Tsai, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
November 13, 2014
BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer
L Flanagan, A U Lindner, C de Chaumont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy
Mark S Carey, Roshan Agarwal, Blake Gilks, et al.
BMC Medicine
|
April 13, 2017
S100β as a serum marker in endocrine resistant breast cancer
Sara Charmsaz, Éamon Hughes, Fiona T Bane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Pharmacodynamic markers of perifosine efficacy
Bryan T Hennessy, Yiling Lu, Enrique Poradosu, et al.
Page
of 25